• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
TYP

TRYPTAMINE THERAPEUTICS LIMITED - Corporate Spotlight

5.56% ! 3.4¢
Currently unlisted.
Healthcare Biotechnology
Add to My Watchlist

Tryptamine Therapeutics Limited is an Australia-based clinical-stage biotechnology... Tryptamine Therapeutics Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing proprietary, novel formulations for the administration of psilocin in combination with psychotherapy to treat diseases with unmet medical needs. It is focused on bringing transformative medicine with known safety profiles to diseases with no effective first-line treatments. Its lead program, TRP-8803, is a proprietary formulation of IV-infused psilocin (the active metabolite of psilocybin) with potential to alleviate numerous shortcomings of oral psilocybin It intends to accomplish this through the development of an IV infusion of psilocin Its lead programs are designed to address neuropsychiatric disorders through the therapeutic dosing of synthetic psilocybin and IV infused psilocin in conjunction with psychotherapy. It has completed phase II clinical trials for the treatment of binge eating disorder. Its pipeline products include TRP-8803 and TRP-8802.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

No Corporate Spotlight currently available.

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Top Stories

Gold Mountain unveils new rare earths potential West of Irajuba

Gold Mountain (ASX: GMN) believes the Down Under project area in Brazil has significant REE upside following further success there.
Leeuwin Metals kicks off CY26 drilling with high-grade gold at Evanston The latest HotCopper Watchlist, where we’ve spoken to Leeuwin Metals MD Chris Piggott about the gold explorer's first CY26 drilling results.
Listen: HotCopper Wire Podcast #041 – Our first RBA rate hike since CY23 On the HotCopper Wire this week, JD and I unpack the RBA's first "hike" since CY23 and Trump's $12B stockpile, and call a "crypto winter."
HotCopper Trends: Resolution Minerals, scandium hits, Paradigm Biopharma and more With more than seven million users on the HotCopper forums, every discussion and speculation can move Australian markets, which is why getting out in front of those trends is so important for any trader worth their salt.Listen to the HotCopper podcast for in-depth discussions and insights on all ...
Olympio Metals confirms priority gold target at Bousquet Olympio Metals (ASX: OLY) has obtained promising soil sampling results from the Bousquet gold project in Canada.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.